ロード中...
Paricalcitol for Secondary Hyperparathyroidism in Renal Transplantation
Secondary hyperparathyroidism contributes to post-transplant CKD mineral and bone disorder. Paricalcitol, a selective vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in patients with secondary hyperparathyroidism. This single-center, prospective, randomized,...
保存先:
| 出版年: | J Am Soc Nephrol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Nephrology
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4413751/ https://ncbi.nlm.nih.gov/pubmed/25194004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013111185 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|